Earlier this month, Mesoblast announced that its therapy Ryoncil received a permanent Healthcare Common Procedure Coding System (HCPCS) J-Code from the US Centers for Medicare and Medicaid Services, ...

For now, the most reasonable stance is watchful waiting: acknowledging the real problems WISeR seeks to address, recognizing ...

Medicare beneficiaries with amyotrophic lateral sclerosis (ALS) were found to have more than 3 times the Medicare expenditures and beneficiary liability of the average Medicare beneficiary.

Ah, fall—the season of pumpkin spice, political ads, and the annual flood of cheery voices promising to “simplify” your ...

NEW YORK, Oct. 19, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided highlights of its recent ...

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi, part of the global healthcare company Fresenius, and a leading provider of essential medicines and medical technologies, announced today the ...